Background {#Sec1}
==========

Severe brain injuries, such as traumatic brain injury (TBI), intracranial hemorrhage or stroke are a common cause of intensive care unit (ICU) admission and mechanical ventilation initiation \[[@CR1]\]. Mechanical ventilation is frequently applied to protect the airway from the risk of aspiration and to prevent both hypoxemia and hypercapnia, which are two major systemic factors of secondary brain insult. Recent guidelines \[[@CR2]\] recommend that prolonged prophylactic hyperventilation with PCO~2~ ≤ 25 mmHg should be avoided, but the ventilator settings, including those to set tidal volume or positive end-expiratory pressure (PEEP), remain undetailed. Observational data suggest that brain injury patients are delivered higher tidal volume and lower PEEP levels than non-neurological patients \[[@CR3]\] but they have longer mechanical ventilation duration, and higher rates of hospital-acquired pneumonia \[[@CR4], [@CR5]\], tracheostomy and mortality than non-neurologic patients \[[@CR3]\]. The respiratory management is further complex because weaning these patients from mechanical ventilation and the decision to extubate remain two challenging issues \[[@CR6]\]. Indeed, guidelines for the weaning of mechanical ventilation in ICU patients were developed 10 years ago \[[@CR7]\], but owing to the lack of robust evidence in the literature, no clear recommendations are currently available in the neuro-ICU setting.

Interest in the respiratory management of brain injury patients has increased recently. In particular, the use of protective ventilation in the early phase of brain injury \[[@CR8], [@CR9]\] has been evaluated, and new data regarding the criteria compatible with successful extubation \[[@CR10]--[@CR12]\] have been gathered.

In this chapter, we will focus on the most recent data available in the neuro-ICU field regarding respiratory management, from the early phase of mechanical ventilation initiation to liberation from mechanical ventilation and extubation.

Historical Practices in Mechanical Ventilation {#Sec2}
----------------------------------------------

### Tidal Volume {#Sec3}

After brain injury, impaired consciousness and brain-stem reflexes induce hypoventilation and lead to aspiration. The first aim of mechanical ventilation is to protect the airway through tracheal intubation. Current guidelines recommend that endotracheal intubation should be performed systematically when the Glasgow Coma Score (GCS) is ≤8 \[[@CR2]\]. In the first days after brain injury, hypoxemia and hyper/hypocapnia lead to secondary brain insults, which alter the outcome \[[@CR13]\]. Treatment of hypoxemia consists of increasing the inspired oxygen fraction (FiO~2~) delivery with a target of PaO~2~ \> 60 mmHg \[[@CR2]\], which can be modified if brain ischemia is diagnosed by multimodal monitoring (low tissue oxygen tension \[PtiO~2~\] and low jugular venous oxygen saturation \[SvjO~2~\]) \[[@CR14]\]. PaCO~2~ is a powerful determinant of cerebral blood flow (CBF), which impacts intracranial pressure (ICP) \[[@CR2]\]. An adequate control of PaCO~2~ within a 32--45 mmHg range, even at the very early phase, was associated with a better outcome \[[@CR15]\]. The maintenance of normal levels of PaCO~2~ is thus recommended throughout the TBI course \[[@CR2]\]. Nonetheless, no consensus is available to set the respiratory rate and the tidal volume in order to reach the PaCO~2~ target, and in daily practice, practitioners usually increase tidal volume, in order to provide better PaCO~2~ control (Table [1](#Tab1){ref-type="table"}).Table 1Evolution of respiratory care bundle in patients with brain injury \[[@CR8]--[@CR12]\]Current practiceEvolution of practiceTidal volume\>  8 ml/kg IBW6--7 ml/kg IBWPEEP0--3 cmH~2~O≥ 5 cmH~2~OExtubation managementAwaiting recovery or awarenessNegative fluid balance\
Cough\
Gag reflex\
VISAGE score:\
-- Age \< 40\
-- GGS \> 10\
-- Visual pursuit\
-- SwallowingTracheostomy management??*PEEP* positive end-expiratory pressure, *GCS* Glasgow Coma Score, *IBW* ideal body weight

In a multicenter nationwide observational study, patients with brain injury had a comparable mean tidal volume compared to non-neurologic patients, with a median of 9 ml/kg of ideal predicted body weight \[[@CR3]\]. However, a significantly lower proportion of patients with intracranial hemorrhage (15%) received protective ventilation on day 1 of mechanical ventilation, probably because of the fear of hypercapnia \[[@CR3]\]. Because lung injuries were observed in animal models of brain injury and associated with the release of danger-associated molecular patterns (DAMPs) and with lung injury \[[@CR16]\], it is reasonable to propose that brain injury is a risk factor for ventilator-induced lung injury (VILI) and that low tidal volume could be of interest in these patients. Indeed, it is now well established that high tidal volume ventilation leads to VILI \[[@CR17]\] and, in neurologic ICU studies, the use of high tidal volume is associated with an increased rate of acute respiratory distress syndrome (ARDS), worsening outcomes \[[@CR18]\].

### Low Positive End-expiratory Pressure {#Sec4}

PEEP increases the intrathoracic pressure and consequently may impair the central venous return leading to increased ICP. In a study performed in nine patients with brain injury \[[@CR19]\], the authors showed a positive correlation between PEEP and ICP during recruitment maneuvers. However, in an experimental study in healthy pigs, PEEP increase did not affect ICP \[[@CR20]\]. In patients with subarachnoid hemorrhage \[[@CR20]\], PEEP impaired CBF by a decrease in mean arterial pressure (MAP) although ICP was not altered. It has therefore been advocated to use low or null PEEP in mechanically ventilated patients with brain injury, and 80% of patients with brain injury receiving mechanical ventilation, are delivered a PEEP ≤5 cmH~2~O \[[@CR3]\].

### Weaning from Invasive Mechanical Ventilation and Extubation {#Sec5}

The population of severe brain injury patients is at high risk of extubation failure with rates up to 38% \[[@CR21]\]. Currently, no strategy has been described regarding weaning or extubation and brain injury patients were hardly described in the latest guidelines \[[@CR7]\]. The clinical features and level of arousal compatible with successful extubation are still debated in brain injury patients and, therefore, the rates of extubation failure and delayed extubation remain high in this population. Extubation failure is associated with significant morbidity: nosocomial pneumonia, longer mechanical ventilation duration, increased ICU length of stay and higher mortality \[[@CR6], [@CR10], [@CR11]\], but the cause of extubation failure is probably more deleterious than the failure itself \[[@CR6]\]. The fear of extubation failure explains the high rate of delayed extubation in neuro-ICU patients (extubation is considered as delayed when patients are not extubated within 48 h of meeting defined readiness criteria \[[@CR6]\]), even though delaying extubation is not a guarantee of success \[[@CR6]\]. Delaying extubation leads to an increased rate of pneumonia altering the neurological outcome; the high rate of delayed extubation also increases healthcare costs \[[@CR6]\].

New Perspectives: How to Set Mechanical Ventilation in Clinical Practice {#Sec6}
------------------------------------------------------------------------

There was a recent reappraisal about the effects of PEEP on cerebral perfusion pressure (CPP). In a retrospective study in 341 patients \[[@CR22]\], the authors noted a statistically significant decrease in CPP with increase in PEEP, but CPP remained within the therapeutic target. Moreover, no data were provided about the patients' volemic status; this is important because PEEP may alter CPP in hypovolemic conditions. In a pilot prospective study performed in 20 patients with TBI and ARDS \[[@CR23]\], the authors increased PEEP up to 15 cmH~2~O. There was no significant change in ICP or CPP and, importantly, the authors reported a significant improvement in brain tissue oxygenation with higher levels of PEEP. In conclusion, it seems that an increase in PEEP can be safely applied in ARDS patients with brain injury, provided that they are normovolemic, and may even have beneficial cerebral effects. Our group recently confirmed the safety of PEEP by showing that PEEP \> 5 cmH~2~O did not alter the ICP in patients with severe brain injury \[[@CR9]\].

The use of low tidal volume within a protective ventilation strategy in the general ICU population with ARDS \[[@CR24]\] or in the perioperative setting \[[@CR25]\], is strongly associated with improved outcomes. Our group recently evaluated, in two before-after studies, the efficacy of a protective ventilation strategy in patients with brain injury:A study \[[@CR8]\] in two ICUs including 499 patients evaluated a bundle of care with a protective ventilation strategy (tidal volume between 6 and 8 ml/kg of ideal predicted bodyweight and PEEP \> 3 cmH~2~O) and early extubation (when GCS ≥ 10 and cough was obtained). An improvement in the number of ventilatory-free days was observed during the intervention period.A multicenter nationwide before-after study in 749 brain injury patients was conducted to evaluate the effects of protective ventilation (≤ 7 ml/kg of ideal predicted body weight and a PEEP between 6 and 8 cmH~2~O) associated with early extubation \[[@CR9]\]. There was no difference in the number of ventilatory-free days at day 90 between the two periods. However, in the subgroup of patients in which all the recommendations were applied (protective ventilation and early extubation), there was a significant improvement in the number of ventilator free days at day 90 and in the mortality rate.

In both these studies \[[@CR8], [@CR9]\], the use of protective ventilation did not alter outcomes or impair ICP provided that the level of PaCO~2~ was monitored and maintained within normal ranges. These results also provide important, simple and applicable data to attending physician on how to reach the goals of PaCO~2~ suggested by international guidelines \[[@CR2]\] with a strategy of modifying respiratory rate rather than tidal volume.

When Should we Perform Extubation After Brain Injury? {#Sec7}
-----------------------------------------------------

The level of arousal is a major issue in deciding when to safely perform extubation, but multiple pitfalls persist in its bedside evaluation. Coplin et al. pointed out that delaying extubation, in order to wait for sufficient neurological recovery, did not guarantee successful extubation and was associated with increased nosocomial pneumonia, ICU and hospital lengths of stay and costs \[[@CR6]\]. Navalesi et al. proposed algorithm-based extubation when patients displayed a GCS ≥ 8 with audible cough during suctioning, and showed a significant improvement in extubation success \[[@CR26]\]. Namen et al. showed that a GCS of 8 had the highest area under the receiver operating curve for predicting successful extubation \[[@CR21]\].

Surprisingly, in a multicenter study including 192 patients, and in a monocenter cohort of 140 patients \[[@CR11]\], higher GCS was not associated with extubation success \[[@CR12]\]. A major limitation potentially explaining the discrepancies between these studies is that the GCS has never been validated in intubated patients, and it should be remembered that quantification of the verbal component is impossible in intubated patients, especially after brain injury. Some authors have arbitrarily decided to score the verbal component as 1 in all intubated patients \[[@CR6]\], whereas others chose to score the verbal component as 1 in non-communicating patients and as 4 in patients who tried to speak with the endotracheal tube \[[@CR10]\]. In other studies \[[@CR21], [@CR26]\], the evaluation of the verbal component is not available. This observation may explain why the GCS has been inconsistently reported as a factor associated with extubation success, and other tools of arousal evaluation are mandatory.

Further specific neurologic features compatible with safe extubation have been identified. In a multicenter study performed in 437 patients, our group aimed to develop a standardized specific physical examination on the day of extubation that could predict extubation success \[[@CR10]\]. Age \< 40 years old, visual pursuit, attempts to swallow and a GCS \> 10 on the day of extubation were independent markers of successful extubation. Based on these four items, the predictive VISAGE score was built, which predicted at least 90% of episodes of extubation success when three items were present. In another monocenter study in 140 patients \[[@CR11]\], visual pursuit and preserved upper airway reflexes were predictive factors of extubation success. In 192 patients \[[@CR12]\], in another monocenter study, younger age, negative fluid balance and the presence of cough were predictive factors. Cough was also identified as predictive in a monocenter study in 311 patients with TBI \[[@CR27]\]. We summarize the clinical features that may predict successful extubation after brain injury in Table [1](#Tab1){ref-type="table"}. Large multicenter studies need to be performed to better delineate the impact of predictive factors of extubation success in order to enhance the benefit/risk balance in the decision to extubate and improve outcomes of brain injury patients (Table [2](#Tab2){ref-type="table"}).Table 2Description of extubation failure rates and in-intensive care unit (ICU) mortality in brain-injured patientsFirst author \[ref\]Number of patients with brain injuryBaseline GCSGCS at extubationExtubation failure rate (%)In-ICU mortality rate (%)Navalesi \[[@CR26]\] (intervention/control groups)165/1539.4 ± 1.9/9.3 ± 1.910.6 ± 0.7/10.5 ± 0.95/121/4Qureshi \[[@CR32]\]69UnknownUnknown6739Reis \[[@CR35]\] (success/failure groups)3119.7 ± 4.4Unknown13.83/14Coplin \[[@CR6]\]136UnknownUnknown17.416.1Namen \[[@CR21]\] (intervention/control groups)100Unknown8.3 ± 2.63841/31Karanjia \[[@CR36]\]1265Unknown11 ± 36.1UnknownWendell \[[@CR37]\] (success/failure groups)3711 (8--14)/11.5 (7--14)13 (9--14)/10.5 (8--14)218/20Godet \[[@CR11]\] (success/failure groups)1408 (5--11)/6 (4--9)9 (8--10)/9 (7--10)311/19McCredie \[[@CR12]\] (success/failure groups)1927 (4--9)/7(6--9)9(8--10)/9(8--10)211/13Asehnoune \[[@CR10]\] (success/failure groups)4377(5--10)/7(3--10)11 (10--14)/11 (9--13)22.61.2/11.1*GCS* Glasgow Coma Scale expressed as mean (±standard deviation) or median (interquartile) accordingly. In-ICU mortality is displayed for the entire cohort or according to the extubation success/failure group and the intervention/control group whenever appropriate

When Should we Perform Tracheostomy After Brain Injury? {#Sec8}
-------------------------------------------------------

Owing to the complicated extubation process in patients with brain injury, tracheostomy appears an interesting approach. Debate remains over the benefit of early versus late tracheostomy \[[@CR28]\] because early tracheostomy may be associated with an increase in the number of ventilator-free days. Data on the subject are scarce in the neuro-ICU literature (Table [3](#Tab3){ref-type="table"}). Two recent studies have used large databases to assess the potential effects of early versus late tracheostomy. In the first monocenter retrospective study performed in a trauma population \[[@CR29]\], a propensity analysis matched for head and chest injury favored early tracheostomy with less pneumonia, lower mechanical ventilation duration and ICU length of stay. The second retrospective multicenter study in 1811 TBI patients \[[@CR30]\] also supported an early tracheostomy policy. The mortality rate was similar between patients with early and late tracheostomy in both studies. The main issue is that these analyses are extracted from databases in which the reason why tracheostomy was performed is unknown. These results were challenged in a randomized parallel-group, controlled, open study in stroke patients \[[@CR31]\] in which early tracheostomy did not result in a reduction in the ICU length of stay, which was the primary outcome, but resulted in lower mortality. This result should be cautiously interpreted because only 60 patients were included and mortality was a secondary outcome.Table 3Description of tracheostomy and mortality rates in patients with severe brain injuryFirst author \[ref\]Number of patientsTracheostomy, n (%)General in-ICU mortality, n (%)In-ICU mortality in patients with tracheostomy, n (%)Navalesi \[[@CR26]\]31816 (5)8 (2)UnknownQureshi \[[@CR32]\]6923 (33)27 (39)UnknownReis \[[@CR35]\]31129 (9)21 (6)UnknownCoplin \[[@CR6]\]1364 (3)22 (16.1)UnknownNamen \[[@CR21]\]10029 (29)36 (36)UnknownKaranjia \[[@CR36]\]1265181 (14)UnknownUnknownWendell \[[@CR37]\]373 (8)5 (13.5)UnknownGodet \[[@CR11]\]1409 (6.4)9 (6.4)UnknownAsehnoune \[[@CR10]\]43740 (9.1)15 (3.4)2 (0.4)*ICU* intensive care unit

In clinical practice, early tracheostomy is not recommended but could be considered in situations with high risk of extubation failure like infra-tentorial lesions \[[@CR32]\], protracted mechanical ventilation or in patients with poor neurological recovery and/or after extubation failure.

Extubation, Tracheostomy and Withdrawal of Life-sustaining Therapies After Brain Injury {#Sec9}
---------------------------------------------------------------------------------------

A major clinical issue regarding extubation and tracheostomy in the neuro-ICU setting, is that physicians fear that tracheostomy may facilitate weaning the patient from mechanical ventilation but sometimes with unacceptable neurologic damage. Extubation may be the last step of withdrawal of life-sustaining therapies. This practical aspect of end-of-life care has not been adequately addressed in neuro-ICU patients. A descriptive monocenter study confirmed that mechanical ventilation discontinuation accounted for 50% of deaths in a population of neurovascular patients (stroke, intracerebral hemorrhage or subarachnoid hemorrhage) \[[@CR33]\]. In most studies regarding extubation in brain injury patients, patients undergoing withdrawal of life-sustaining therapies are not included \[[@CR10], [@CR11]\], but the timing, modalities and consequences of extubation in this context are not addressed in the neuro-ICU literature.

Withdrawal of life-sustaining therapies is a complex process and its modalities after brain injury cannot be reduced only to extubation, which could remain successful even in comatose patients \[[@CR6], [@CR10]--[@CR12]\].

Conclusion {#Sec10}
==========

Revisiting current strategies for respiratory management in patients with acute brain injury is important because no clear recommendations are currently available and respiratory management in general may impact neurological outcomes. It is now clear that PEEP has minor effects on CPP in euvolemic patients and could even have positive consequences on brain tissue oxygenation. Protective ventilation, with low tidal volumes (6--8 ml/kg of ideal body weight), can be safely performed after brain injury, but its positive effects on outcome have to be better delineated. Extubation remains challenging in the neuro-ICU setting. Waiting for a patient's full neurological recovery is not mandatory and some specific features, such as visual pursuit, cough, and deglutition, may help the attending physician to perform extubation. Tracheostomy can be considered, but the best timing and the selection of patients who might benefit from this strategy remain unknown. Finally, the development of quality improvement projects is a crucial step in improving outcomes of patients with acute brain injury \[[@CR34]\].
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